| Product NDC: | 57896-455 |
| Proprietary Name: | Senna Plus |
| Non Proprietary Name: | Sennosides and Docusate Sodium |
| Active Ingredient(s): | 50; 8.6 mg/1; mg/1 & nbsp; Sennosides and Docusate Sodium |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 57896-455 |
| Labeler Name: | Geri-Care Pharmaceutical Corp |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part334 |
| Marketing Category: | OTC MONOGRAPH NOT FINAL |
| Start Marketing Date: | 20000101 |
| Package NDC: | 57896-455-01 |
| Package Description: | 100 TABLET in 1 BOTTLE (57896-455-01) |
| NDC Code | 57896-455-01 |
| Proprietary Name | Senna Plus |
| Package Description | 100 TABLET in 1 BOTTLE (57896-455-01) |
| Product NDC | 57896-455 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Sennosides and Docusate Sodium |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20000101 |
| Marketing Category Name | OTC MONOGRAPH NOT FINAL |
| Labeler Name | Geri-Care Pharmaceutical Corp |
| Substance Name | DOCUSATE SODIUM; SENNOSIDES |
| Strength Number | 50; 8.6 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes |